438 results on '"Ozgocmen, Salih"'
Search Results
2. Facteurs de risque cardiovasculaire chez des patients atteints de spondyloarthrite originaires du nord de l’Europe et des pays méditerranéens : une étude dérivée du projet Asas-Comospa
3. Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project
4. Decreased Femoral Cartilage Thickness in Patients With Systemic Sclerosis
5. Neuropathic Pain Component in Axial Spondyloarthritis and the Influence on Disease Burden
6. Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables
7. Abnormal heart rate recovery on exercise in ankylosing spondylitis
8. Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever
9. Is there any gender‐specific difference in the cut‐off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
10. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study
11. Non-pharmacological management in axial spondyloarthritis
12. Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis
13. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis
14. Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
15. Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
16. Osteopoikilosis and ankylosing spondylitis: a rare coexistence and good response to TNF blocker adalimumab
17. MR-defined fat infiltration of the lumbar paravertebral muscles differs between non-radiographic axial spondyloarthritis and established ankylosing spondylitis
18. Prevalence of atopic disorders in rheumatic diseases
19. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis
20. Current Concept of Spondyloarthritis: Special Emphasis on Early Referral and Diagnosis
21. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature
22. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients
23. Clinical and MRI findings of brucellar spondylodiscitis
24. Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis
25. Is iontophoresis really an effective modality for the treatment of dactylitis?
26. The reliability of the clinical examination for detecting Bakerʼs cyst in asymptomatic fossa
27. The value of sacroiliac pain provocation tests in early active sacroiliitis
28. Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis.
29. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
30. Assessment of enthesitis in ankylosing spondylitis by power Doppler ultrasonography
31. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns
32. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide
33. Familial Mediterranean fever responds well to infliximab: single case experience
34. Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia–reperfusion-induced oxidative stress
35. Réponse de phase aiguë, paramètres cliniques et activité inflammatoire dans la spondylarthrite ankylosante
36. Clinical and radiological diagnosis of progressive pseudorheumatoid dysplasia in two sisters with severe polyarthropathy
37. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity
38. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis
39. Physiotherapy and rehabilitation in ankylosing spondylitis: is it still the mainstay of management in the era of biologics?
40. Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever
41. Infliximab and brucellosis: not the usual suspects, this time
42. Expert opinion and key recommendations for the physical therapy and rehabilitation of patients with ankylosing spondylitis
43. Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis
44. Bone mineral density in patients with Parkinson’s Disease
45. Glucocorticoid iontophoresis for Achilles tendon enthesitis in ankylosing spondylitis: significant response documented by power Doppler ultrasound
46. Evaluation of a Quantitative Scoring of Enthesitis in Ankylosing Spondylitis
47. Clinical Presentation of Cutaneous Manifestations in Complex Regional Pain Syndrome (Type 1)
48. Clinical evaluation and power doppler sonography in rheumatoid arthritis: evidence for ongoing synovial inflammation in clinical remission
49. Spontaneous regression of herniated lumbar intervertebral disc
50. Power Doppler Assessment of Overall Disease Activity in Patients with Rheumatoid Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.